In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

Powered by its popular GLP-1 weight loss drugs, Eli Lilly's stock (NYSE: LLY) has had a strong run this year, up more than 55 ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

While patients with Parkinson’s initially start taking oral drugs like levodopa and carbidopa ... patients who cannot have apomorphine, with a list price of £84.70 per vial ahead of discounts.

Academy Award winning actor Anne Hathaway is celebrating her 42nd birthday today and on the occasion, we have a list of her ...

A new study shows that a common glaucoma drug cleared tau build-up and reduced signs of neurodegenerative disease in zebrafish and mice.

A group of over 80 Canadian academics is urging the federal government to halt the importation of endangered macaque monkeys ...

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...